A phase 1 study with cisplatin and pemetrexed administered before or after stereotactic radiotherapy (SRT) in patients with stage IB non-small-cell lung cancer (NSCLC).
Recruiting
- Conditions
- non-small-cell lung cancer. longkanker
- Registration Number
- NL-OMON23245
- Lead Sponsor
- prof. dr. EF Smit
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
1. Any histologically or cytologically proven NSCLC;
2. Stage IB NSCLC (T2N0M0);
Exclusion Criteria
1. Pregnant or lactating women;
2. Concomitant treatment with any other experimental drug under investigation;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety and feasibility of sequential chemotherapy and SRT.
- Secondary Outcome Measures
Name Time Method ocal control, disease progression and quality of life.